GlassScriptPhysician profile
Daniel Savino
NPI 1568059889
$613.12
in general payments reported to CMS, 2019-2025
15 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.52 · 2023: $58.16 · 2024: $16.96 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $138.48 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.72 | 2025 | Lifevest |
| Amgen INC. | $58.66 | 2025 | Repatha |
| Csl Behring | $58.16 | 2023 | Kcentra |
| Bayer Healthcare Pharmaceuticals INC. | $38.03 | 2025 | |
| Bridgebio Pharma, INC. | $38.00 | 2025 | Attruby |
| Lilly USA, LLC | $36.28 | 2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $33.00 | 2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $32.50 | 2025 | Camzyos |
| Medtronic, INC. | $21.81 | 2025 | Symplicity G3 |
| Abiomed | $20.60 | 2025 | |
| Heartflow, INC. | $16.55 | 2025 | |
| Esperion Therapeutics, INC. | $15.93 | 2025 | Nexletol |
| Ionis Pharmaceuticals, INC. | $14.88 | 2025 | Tryngolza |
| Haemonetics Corporation | $14.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Savino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.